The combined effects of telmisartan and ramipril on hypertension and cardiovascular injury

다국어 초록 (Multilingual Abstract)

Purpose More than half of hypertensive patients receive combination therapy with two or more drugs. For combination therapy with antihypertensive drugs, it is recommended to use complementary drugs with different mechanisms. In this study, the effects of combination therapy with telmisartan (an angiotensin II receptor type 1 blocker) and ramipril (an angiotensinconverting enzyme inhibitor) on blood pressure control and cardiovascular protection were verified.
Methods The systolic blood pressure (SBP), mean arterial pressure (MAP), and heart rate of spontaneously hypertensive rats (SHRs) were measured using a telemetry system. The protective effect of the drug combination against cardiovascular injury was determined by examining ligation-induced myocardial ischemia/reperfusion in SHRs and cuff-induced neointimal formation in C57BL/6 mice.
Results The combination therapy with telmisartan and ramipril significantly decreased SBP and MAP. In addition, the combination therapy significantly increased the expression of endothelial nitric oxide synthase and inhibited the proliferation of vascular smooth muscle cells by inhibiting DNA synthesis at the cuff-induced vascular injury site.
Conclusion The results of this study suggest that combination therapy with telmisartan and ramipril is an effective strategy for the treatment of hypertension and complications of hypertensive disorders.

참고문헌 (Reference)

1 Brown IM, "Vascular smooth muscle remodeling in conductive and resistance arteries in hypertension" 38 : 1969-1985, 2018

2 Intengan HD, "Vascular remodeling in hypertension : roles of apoptosis, inflammation, and fibrosis" 38 : 581-587, 2001

3 Li HG, "Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease" 13 : 161-167, 2013

4 Armario P, "Therapeutic strategies to improve control of hypertension" 31 (31): S9-S12, 2013

5 Liu L, "The felodipine event reduction(fever)study : a randomized long-term placebo controlled trial in Chinese hypertensive patients-Design and principal results" 23 : S118-S118, 2005

6 박현수 ; 이도형 ; 한주희 ; Jung Sang-Hyuk ; Lee Miji ; 장근우 ; 명창선, "The effects of combined treatment of losartan and ramipril on hypertension and related complications" 한국약제학회 50 (50): 573-581, 2020

7 Siragusa M, "The eNOS signalosome and its link to endothelial dysfunction" 468 : 1125-1137, 2016

8 박현수 ; 한주희 ; 정상혁 ; 조은지 ; 명창선, "The combination of valsartan and ramipril protects against blood vessel injury and lowers blood pressure" 한국약제학회 46 (46): 265-272, 2016

9 ONTARGET Investigators, "Telmisartan, ramipril, or both in patients at high risk for vascular events" 358 : 1547-1559, 2008

10 Akhrass PR, "Telmisartan and cardioprotection" 7 : 677-683, 2011

11 Sharpe M, "Telmisartan : a review of its use in hypertension" 61 : 1501-1529, 2001

12 Bakheit AH, "Telmisartan" 40 : 371-429, 2015

13 Chang-Yong Shin ; 명창선 ; Woon-Seok Choi ; Inseon Yi ; Mei-Hua Nan, "Synergistic Decrease in Blood Pressure by Captopril Combined with Losartan in Spontaneous Hypertensive Rats" 대한약학회 32 (32): 955-962, 2009

14 Warner GT, "Spotlight on ramipril in the prevention of cardiovascular outcomes" 3 : 113-116, 2003

15 Kulandavelu S, "Regulation of oxygen delivery to the body via hypoxic vasodilation" 112 : 6254-6255, 2015

16 Rokoss MJ, "Ramipril in the treatment of vascular diseases" 6 : 1911-1919, 2005

17 Warner GT, "Ramipril : a review of its use in the prevention of cardiovascular outcomes" 62 : 1381-1405, 2002

18 Benetos A, "Pulse pressure : a predictor of long-term cardiovascular mortality in a French male population" 30 : 1410-1415, 1997

19 Galzerano D, "New standards in hypertension and cardiovascular risk management : focus on telmisartan" 6 : 113-133, 2010

20 Aoki A, "Long-term effects of telmisartan on blood pressure, the renin-angiotensin-aldosterone system, and lipids in hypertensive patients" 25 : 195-202, 2010

21 Kokubo Y, "Impact of highnormal blood pressure on the risk of cardiovascular disease in a Japanese urban cohort : the Suita Study" 52 : 652-659, 2008

22 Nguyen Q, "Hypertension management : an update" 3 : 47-56, 2010

23 Te Riet L, "Hypertension : renin-angiotensin-aldosterone system alterations" 116 : 960-975, 2015

24 Akbarpour S, "Healthy lifestyle behaviors and control of hypertension among adult hypertensive patients" 8 : 8508-, 2018

25 Collaborators GBDRF, "Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016 : a systematic analysis for the global burden of disease study 2016" 390 : 1345-1422, 2017

26 Inseon Yi ; 이정진 ; 박정숙 ; Wei Yun Zhang ; In-Su Kim ; Yohan Kim ; Chang-Yong Shin ; 김형식 ; 명창선, "Enhanced Effect of Losartan and Rosuvastatin on Neointima Hyperplasia" 대한약학회 33 (33): 593-600, 2010

27 Turnbull F, "Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus : results of prospectively designed overviews of randomized trials" 165 : 1410-1419, 2005

28 Elmer PJ, "Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control : 18-month results of a randomized trial" 144 : 485-495, 2006

29 Jo Jun-Hwan ; 이도형 ; 한주희 ; Lee Miji ; 장근우 ; 명창선, "Effects of combination treatment with cilnidipine and telmisartan on hypertension, cardiovascular injury, and high blood glucose" 한국약제학회 51 (51): 337-346, 2021

30 이도형 ; 조은지 ; 가은지 ; 한주희 ; 정상혁 ; 박현수 ; 허경선 ; 명창선, "Effects of combination therapy with candesartan and ramipril on hypertension and related complications" 한국약제학회 47 (47): 365-371, 2017

31 Avezum A, "Effect of ramipril on the incidence of diabetes" 355 : 1551-1562, 2006

32 Mann JF, "Dual inhibition of the renin-angiotensin system in high-risk diabetes and risk for stroke and other outcomes : results of the ONTARGET trial" 31 : 414-421, 2013

33 이정진 ; Chang-Yong Shin ; Hong-Joon Park ; Wei-Yun Zhang ; Yohan Kim ; In-Su Kim ; 이규현 ; 명창선, "Drug Synergism of Antihypertensive Action in Combination of Telmisartan with Lercanidipine in Spontaneous Hypertensive Rats" 대한약학회 33 (33): 1411-1418, 2010

34 Park ES, "Cordycepin, 3’-deoxyadenosine, prevents rat hearts from ischemia/reperfusion injury via activation of Akt/GSK-3β/p70S6K signaling pathway and HO-1 expression" 14 : 1-9, 2014

35 Guerrero-Garcia C, "Combination therapy in the treatment of hypertension" 7 : 212531-, 2018

36 Gorostidi M, "Combination therapy in hypertension" 30 : 320-336, 2013

37 Ettehad D, "Blood pressure lowering for prevention of cardiovascular disease and death : a systematic review and meta-analysis" 387 : 957-967, 2016

38 Brunstrom M, "Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels : a systematic review and meta-analysis" 178 : 28-36, 2018

39 Berl T, "Angiotensin-converting enzyme inhibitors versus AT1receptor antagonist in cardiovascular and renal protection: the case for AT1receptor antagonist" 15 (15): S71-S76, 2004

40 Barreras A, "Angiotensin II receptor blockers" 16 : 123-126, 2003

41 Miranda RD, "An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension : the assessment of combination therapy of amlodipine/ramipril(ATAR)study" 30 : 1618-1628, 2008

42 Lewington S, "Age-specific relevance of usual blood pressure to vascular mortality : a meta-analysis of individual data for one million adults in 61 prospective studies" 360 : 1903-1913, 2002

43 Kostis WJ, "ACE inhibitorinduced angioedema : a review" 20 : 55-, 2018

44 Nair AB, "A simple practice guide for dose conversion between animals and human" 7 : 27-31, 2016

45 Williams B, "2018 ESC/ESH Guidelines for the management of arterial hypertension : the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension : The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension" 36 : 1953-2041, 2018

46 Williams B, "2018 ESC/ESH Guidelines for the management of arterial hypertension" 39 : 3021-3104, 2018